Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Charles R. Wescott is active.

Publication


Featured researches published by Charles R. Wescott.


Biotechnology Progress | 2002

Development of Mammalian Serum Albumin Affinity Purification Media by Peptide Phage Display

Aaron K. Sato; Daniel J. Sexton; Lee Morganelli; Edward H. Cohen; Qi Long Wu; Greg Conley; Zoya Streltsova; Stan W. Lee; Mary Devlin; Daniel B. DeOliveira; Jasmin Enright; Rachel Baribault Kent; Charles R. Wescott; Tom C. Ransohoff; Arthur C. Ley; Robert Charles Ladner

Several phage isolates that bind specifically to human serum albumin (HSA) were isolated from disulfide‐constrained cyclic peptide phage‐display libraries. The majority of corresponding synthetic peptides bind with micromolar affinity to HSA in low salt at pH 6.2, as determined by fluorescence anisotropy. One of the highest affinity peptides, DX‐236, also bound well to several mammalian serum albumins (SA). Immobilized DX‐236 quantitatively captures HSA from human serum; mild conditions (100 mM Tris, pH 9.1) allow release of HSA. The DX‐236 affinity column bound HSA from human serum with a greater specificity than does Cibacron Blue agarose beads. In addition to its likely utility in HSA and other mammalian SA purifications, this peptide media may be useful in the proteomics and medical research markets for selective removal of mammalian albumin from serum prior to mass spectrometric and other analyses.


Bioconjugate Chemistry | 2012

Fibrin Specific Peptides Derived by Phage Display: Characterization of Peptides and Conjugates for Imaging

Andrew Kolodziej; Shrikumar A. Nair; Philip B. Graham; Thomas J. McMurry; Robert Charles Ladner; Charles R. Wescott; Daniel J. Sexton; Peter Caravan

Peptides that bind to fibrin but not to fibrinogen or serum albumin were selected from phage display libraries as targeting moieties for thrombus molecular imaging probes. Three classes of cyclic peptides (cyclized via disulfide bond between two Cys) were identified with consensus sequences XArXCPY(G/D)LCArIX (Ar = aromatic, Tn6), X(2)CXYYGTCLX (Tn7), and NHGCYNSYGVPYCDYS (Tn10). These peptides bound to fibrin at ∼2 sites with K(d) = 4.1 μM, 4.0 μM, and 8.7 μM, respectively, whereas binding to fibrinogen was at least 100-fold weaker. The peptides also bind to the fibrin degradation product DD(E) with similar affinity to that measured for fibrin. The Tn7 and Tn10 peptides bind to the same site on fibrin, while the Tn6 peptides bind to a unique site. Alanine scanning identified the N- and C-terminal ends of the Tn6 and Tn7 peptides as most tolerant to modification. Peptide conjugates with either fluorescein or diethylenetriaminepentaaceto gadolinium(III) (GdDTPA) at the N-terminus were prepared for potential imaging applications, and these retained fibrin binding affinity and specificity in plasma. Relaxivity and binding studies on the GdDTPA derivatives revealed that an N-terminal glycyl linker had a modest effect on fibrin affinity but resulted in lower fibrin-bound relaxivity.


Nuclear Medicine and Biology | 2002

Nitriles form mixed-coligand complexes with 99mTc-HYNIC-Peptide

Guozheng Liu; Charles R. Wescott; Aaron K. Sato; Yi Wang; Ning Liu; Yumin Zhang; Mary Rusckowski; Donald J. Hnatowich

Using a 12-amino acid peptide conjugated with HYNIC as a model, we investigated nitriles as possible coligands for labeling with (99m)Tc. After the preparation of the (99m)Tc labeled HYNIC-peptide using tricine as coligand, the addition of acetonitile was found by reverse phase HPLC to block further coligand exchange with ethylenediamine diacetic acid (EDDA) at room temperature. The addition of this nitrile changed the pharmacokinetics of the (99m)Tc labeled peptide in normal mice towards faster clearance and significant differences in accumulation in most tissues sampled. By replacing acetonitrile with cyanoacetate, a nitrile not present in the HPLC eluant, it was possible to show the existence of a new, more hydrophilic, species by reverse phase HPLC. We conclude that nitriles can act as coligands for HYNIC-conjugated peptides labeled with (99m)Tc and tricine. Furthermore, the presence of acetonitrile during Sep-Pak or HPLC purification may inadvertently generate a mixed tricine/acetonitile coligand (99m)Tc-HYNIC-peptide complex.


Journal of Biological Chemistry | 2003

Novel peptide inhibitors of angiotensin-converting enzyme 2

Lili Huang; Daniel J. Sexton; Kirsten Skogerson; Mary Devlin; Rodger Smith; Indra Sanyal; Tom J. Parry; Rachel Baribault Kent; Jasmin Enright; Qi-Long Wu; Greg Conley; Daniel B. DeOliveira; Lee Morganelli; Matthew Ducar; Charles R. Wescott; Robert Charles Ladner


Archive | 2001

Fibrin binding moieties useful as imaging agents

Charles R. Wescott; James P. Beltzer; Aaron K. Sato


Journal of Molecular Recognition | 2005

Discovery of high-affinity peptide binders to BLyS by phage display

Tony J. Fleming; Meena Sachdeva; Marko Delic; James P. Beltzer; Charles R. Wescott; Mary Devlin; Robert C. Lander; Viktor Roschke; David M. Hilbert; Daniel J. Sexton


Archive | 2000

Binding moieties for fibrin

Charles R. Wescott; Shrikumar A. Nair; Andrew Kolodziej; James P. Beltzer


Archive | 2003

Fibrinogen binding moieties

Charles R. Wescott; Aaron K. Sato


Archive | 2003

Fragments se fixant au fibrinogene

Charles R. Wescott; Aaron K. Sato


Archive | 2001

Fibrin binding polypeptides useful inter alia in medical imaging processes

Charles R. Wescott; James P. Beltzer; Aaron K. Sato

Collaboration


Dive into the Charles R. Wescott's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge